Jonie Ing Kondracki

Jonie’s practice focuses on capital markets transactions and general corporate and securities matters. She represents private and public companies and investment banks on a variety of securities offerings – including initial public offerings (IPOs), secondary and follow-on offerings, private placements, direct listings and debt offerings, particularly in the technology and life sciences industries. Jonie also advises public companies on corporate and securities matters, including reporting obligations and corporate governance. Jonie is the partner representative of the Cooley San Francisco Women’s Initiative and a member of the firm’s legal education committee.

Jonie’s select IPO experience includes:

• Instacart
• Cue Health*
• LegalZoom
• Day One Biopharmaceuticals*
• Biomea
• Fusion*
• Angion Biomedica*
• Kinnate Biopharma*
• Unity Software
• 89bio*
• Phathom Pharmaceuticals*
• IGM Biosciences*
• CrowdStrike*
• Harpoon Therapeutics
• Ooma*
• Ascendis Pharma*
• New Relic
• Xenon Pharmaceuticals*
• Zendesk*
• AeroHive Networks*
• Castlight Health*

* Indicates underwriter representation

Jonie also represents all of the leading investment banks – including BofA Securities, TD Cowen, Citigroup, Goldman Sachs, Jefferies, J.P. Morgan, Leerink, Morgan Stanley and Stifel.

Jonie was recognized as a Band 4 lawyer in 2023 and 2024 and as an Up and Coming Lawyer in 2021 and 2022 in Capital Markets: Debt & Equity by Chambers USA in both California and Nationwide: Western United States.